MDR-TB

AT2018cow
February 3, 2019
Schengen Area
February 3, 2019

MDR-TB

Multi-drug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs), isoniazid and rifampin.


The public health expert is concerned, because MDR-TB requires long-term medical care which is more expensive and toxic. It also has the ability to reduce the global efforts of eradicating TB.


This is a big concern for India, where TB is the world's largest epidemic and has the largest person with MDR-TB. This year, on the World TB Day (March 24), the Indian government released the nation's first national TB drug-resistance survey. It was found that 6% of patients seeking treatment in government sector have MDR-TB. It is estimated that the percentage of MDR-TB patients in India is likely to increase in the next two decades.

current affair

MDR-TB


Source-THE HINDU

Leave a Reply

Your email address will not be published. Required fields are marked *

0